0001437749-20-008579.txt : 20200427 0001437749-20-008579.hdr.sgml : 20200427 20200427160717 ACCESSION NUMBER: 0001437749-20-008579 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200424 FILED AS OF DATE: 20200427 DATE AS OF CHANGE: 20200427 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FINE N SCOTT CENTRAL INDEX KEY: 0001163556 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-25466 FILM NUMBER: 20820009 MAIL ADDRESS: STREET 1: 600 3RD AVE CITY: NEW YORK STATE: NY ZIP: 10016 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cyclo Therapeutics, Inc. CENTRAL INDEX KEY: 0000922247 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] IRS NUMBER: 593029743 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6714 NW 16TH STREET, SUITE B CITY: GAINSVILLE STATE: FL ZIP: 32653 BUSINESS PHONE: 386-418-8060 MAIL ADDRESS: STREET 1: PO BOX 1180 CITY: ALACHUA STATE: FL ZIP: 32616-1180 FORMER COMPANY: FORMER CONFORMED NAME: CTD HOLDINGS INC DATE OF NAME CHANGE: 20000913 FORMER COMPANY: FORMER CONFORMED NAME: CYCLODEXTRIN TECHNOLOGIES DEVELOPMENT INC DATE OF NAME CHANGE: 19941012 4 1 rdgdoc.xml FORM 4 X0306 4 2020-04-24 0000922247 Cyclo Therapeutics, Inc. CTDH 0001163556 FINE N SCOTT 6714 NW 16TH STREET, SUITE B GAINESVILLE FL 32163 1 1 Chief Executive Officer Common Stock 2020-04-24 4 P 0 730030 0.10 A 7466513 D /s/ N. Scott Fine 2020-04-27